Kidswell Bio Corporation

¥137.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:4584Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR (16.14%)
Div yield —
ROE (19.21%)
Biotechnology
Beta (5Y) 1.20
PE TTM —
TSR TTM (45.85%)
Mkt cap ¥6.933B
ROIC (10.85%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥172
25.82%
(65.28%)
Hold 8|1|1|11|11
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
2.49
2.74
2.91
2.86
28.54%
43.71%
36.76%
25.28%
Revenue¥M
818.8
845.9
861.2
870.0
0.09%
(1.16%)
1.37%
4.31%
Peers (US$44.02M)
Cap (US$)
PE
45.38M
—
44.18M
—
43.88M
—
43.25M
20.79x
Capital
TTM
5Y
10Y
Leveragex
7.643
(0.104)
(0.099)
EBIT/Intx
1.643
0.401
0.325
Own earn%
(483.78)
(162.33)
(106.29)
Sh yield%
56.54
30.08
31.78
Owners
Insiders/Inst%
4.27
74.30
Short interest%
5.73
SBC / revenue%
1.64
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
11–19
$1 testx
−0.1
Incr. ROIC%
8